Clinical Trials Directory

Trials / Completed

CompletedNCT00678028

Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection

Status
Completed
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Due to genetic polymorphism about 15%-30% of the world population have low levels of MBL (Mannose Binding Lectin) in serum (below 500ng/mL). Different studies reported correlation between polymorphism in the MBL gene with low levels of MBL in serum and higher frequency of recurrent infections, severity of sepsis, ARDS and other infections. Urinary Tract Infection (UTI) is one of the very common infection in women. Since MBL is part of the innate immunity and there are proofs of relation between patients with recurrent infections and lack of MBL, we decided to explore a possible relation between low levels of MBL and different genotypes of MBL in young women and the risk to develop recurrent UTI.

Conditions

Timeline

Start date
2008-02-01
First posted
2008-05-15
Last updated
2009-04-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00678028. Inclusion in this directory is not an endorsement.